Management of Hypertensive Disorders of Pregnancy
The guidelines recommend management of common obstetric conditions at primary and referral level, based on local experience and evidence-based practice. They are not intended as strict protocols nor as standard operating procedures, but rather as a guide to safe effective management of common obstetric problems. The guidelines should be most useful to interns, medical officers and registrars.
Inpatient management of mild hypertension or pre-eclampsia
Controlling the blood pressure in pre-eclampsia
Indications for delivery of hypertensive women
ANTENATAL VISITS
Chronic and nonproteinuric hypertensives should attend 4 weekly up to 28 weeks, 2 weekly up to 36 weeks & weekly up to delivery. Women with pre-eclampsia must be admitted to hospital.
PREVENTION OF PRE-ECLAMPSIA
Give aspirin 100 mg orally daily from 12 weeks’ gestation to women with a history of previous pre-eclampsia.
HOSPITAL ADMISSION
Mandatory independent admission criteria for hypertensive patients
- Proteinuria ≥1+ on a midstream specimen
- Symptoms of imminent eclampsia
- Organ dysfunction e.g. thrombocytopenia, liver dysfunction, eclampsia
- Diastolic BP > 110 mmHg
- Systolic BP >160 mmHg
- Antepartum haemorrhage
- Pregnancy at ≥37 weeks
Admission procedure
- Take blood for FBC & U&E
- Order 4 hourly BP & daily urinalysis for protein
- Order NST to be done in the ward if fetus is viable (≥26 weeks)
- Order ultrasound with fetal weight estimation, with umbilical artery Doppler studies if gestation <34 weeks
- Prescribe oral antihypertensive medication
- If BP ≥160/110 mmHg, treat as for severe pre-eclampsia (see below)
INPATIENT MANAGEMENT OF MILD HYPERTENSION OR PRE-ECLAMPSIA
- Doctors' daily round - ask for symptoms of imminent eclampsia, fetal movements, check BP & urine chart, & adjust medication if needed
- Repeat U&E & FBC twice weekly
- Send urine for spot protein:creatinine ratio if urinalysis findings are equivocal
- Send urine for microscopy for casts, and for 24-hour protein estimation if renal disease is suspected
- Do NST on alternate days (if gestation ≥26 weeks)
Treat imminent eclampsia and severe pre-eclampsia as set out below
Discharging hypertensive pregnant patients from the antenatal ward
- The BP must be stable at <160/110 mmHg
- There must be no proteinuria
- The pregnant woman & fetus must both be in generally good condition
- There must be no indication for delivery
- Ensure antihypertensive medication is prescribed
- A return date to antenatal clinic must be given
- A brief discharge summary must be written on the antenatal record
CONTROLLING THE BLOOD PRESSURE IN PRE-ECLAMPSIA
Emergency treatment (BP ≥160/110 mmHg)
- Admit to a high care area
- Preload with 300 mL Ringer-Lactate solution over 20 minutes
- Give nifedipine 10 mg orally as a single dose unless heart rate ≥120/min
- Consider adding magnesium sulphate
- Measure the BP every 30 minutes at first, then hourly
- Repeat nifedipine ½ hourly if necessary (BP still ≥160/110 mmHg)
- Aim for a BP of 140/90 mmHg
- Add maintenance treatment (below)
For unconscious or tachycardic patients, infuse labetalol 200 mg in 200 mL normal saline at 20 mL/hour (i.e. 20 mg/hour, increasing by 20 mg/hour every 30 minutes if necessary, to a maximum of 300 mg in 24 hours). Give 300 mL preload just before starting the infusion. A 20 mg starting bolus may be given.
Maintenance treatment (BP ≥150/100)
The drugs are usually prescribed in a stepwise fashion, depending on response. Aim for a BP of 130-149/90-99 mmHg
- Step 1: Methyldopa 500 mg orally 12 hourly up to a maximum of 750 mg 8 hourly
- Step 2: Add amlodipine 5 mg daily, up to a maximum of 10 mg daily
- Step 3: Add hydralazine 10-50 mg orally 8 hourly
- Step 4: Consider delivery
For chronic hypertensive patients, discontinue beta-blockers, diuretics, & angiotensin converting enzyme inhibitors. Some chronic hypertensive women may not need any medication during pregnancy, because of the physiological fall in blood pressure
INDICATIONS FOR DELIVERY OF HYPERTENSIVE WOMEN
- Pregnancy at 37-40 weeks with gestational & essential hypertension
- Pregnancy ≥37 weeks with mild pre-eclampsia
- Pregnancy ≥34 weeks in severe pre-eclampsia
- Estimated fetal weight ≥1.5 kg in severe pre-eclampsia
- Pregnancy ≤24 weeks or fetus <600 g in severe pre-eclampsia
- Eclampsia
- Imminent eclampsia persisting after treatment with magnesium sulphate
- Cerebral oedema
- HELLP syndrome
- Renal dysfunction (serum urea >8 mmol/L, creatinine >100 µmol/L, urine output <500 mL/24 hours)
- Thrombocytopaenia (platelet count persistently <100´109/L)
- Intrauterine growth restriction
- Fetal distress
- Dead fetus
- Abruptio placentae
SEVERE PRE-ECLAMPSIA
Initial management is as follows:
- Arrange for transfer to a high care area
- Start on Magnesium sulphate to prevent eclampsia
- Insert a urinary catheter & monitor urine output hourly
- Take blood for FBC, U&E, & AST. Do INR if there is thrombocytopaenia as caesarean section may need to be done
- Assess gestational age & fetal weight by ultrasound, with umbilical artery Doppler studies at <32 weeks
- If 24-33 weeks, give betamethasone 12 mg IMI stat, repeat after 12 hours
- Do CTG if fetus is viable (≥26 weeks)
- Treat the high BP
- Arrange for delivery if indications exist & notify paediatricians if the baby is expected to weigh <1500 g.
- If not for delivery, adjust oral antihypertensive medication
- Discharge from high care area, remove IV lines & continue conservative management in the antenatal ward (below)
- Always consider other causes of hypertension e.g. phaeochromocytoma
Exception: Asymptomatic chronic hypertensive patients <20 weeks pregnant can be managed in the antenatal wards without IV lines and catheters.
Conservative management of severe pre-eclampsia (24-33 weeks)
Following stabilisation of BP:
- Continue oral antihypertensive medication
- Twice weekly FBC, U&E, AST, more frequently if necessary
- 6 hourly NST if possible
- Ultrasound fetal assessment for liquor volume & umbilical artery Doppler studies every 2 weeks
- 4 hourly BP, & daily urinalysis for protein
HELLP syndrome
- Initial management is as for severe pre-eclampsia
- In women <34 weeks, plan for delivery within 24-48 hours to allow betamethasone to take effect
- Deliver as soon as possible if <26 weeks or ≥34 weeks
- If platelet count is <50 x 109/L and caesarean section is planned, give platelet transfusion 1 megaunit at operation
ECLAMPSIA
Principles of care are control of convulsions, reduction of BP, clinical & laboratory assessment, & delivery
Immediate management of eclampsia
- Call for help
- Turn the woman onto her side (left lateral)
- Clear the airway – ensure that it is open & remove secretions or vomitus
- Give oxygen by mask
- Prevent injuries, e.g. use cot sides, & remove sharp objects
- Insert an oropharyngeal airway if necessary
- Start an intravenous drip & give magnesium sulphate
- With persistent convulsions or restlessness, give additional magnesium sulphate 2 g IV or clonazepam 1 mg IV over 5 minutes
- Phenytoin has no role in the prevention or management of eclamptic convulsions
- Insert a urinary catheter
- Admit to a high care area
Management of eclampsia after fits have been controlled
- Take blood for FBC, U&E, AST and INR
- Treat the BP if ≥160/110 mmHg
- Continue intravenous fluids (Ringer-Lactate or normal saline) at 70 mL/hour
- Monitor BP, urine output & level of consciousness hourly
- Monitor level of consciousness 2 hourly using GCS or AVPU
- Intubate if GCS ≤8 or responding only to pain
- Assess fetal condition with CTG, & fetal size by ultrasound
- Continue magnesium sulphate infusion at 1 g/hour until 24 hours after delivery or 24 hours after the last convulsion, whichever is later, in a high care area
- Deliver the baby as soon as possible (maximum 12 hours) after the first fit:
- By caesarean section if there is fetal distress or the cervix is unfavourable
- Vaginally if the woman is in labour or if the cervix is favourable for induction (soft, 2-3 cm dilated, fully or almost fully effaced)
- Vacuum extraction or forceps delivery may be necessary in the second stage
- Do not use ergometrine in the third stage (use oxytocin 10 units IM)
- Expect return to full consciousness within two hours of the last fit
- Investigate women with persistent coma or localising signs – call a neurologist to assess and arrange for a computerized tomography (CT) scan of the brain
- Take blood for FBC & U&E on the day after delivery
- Keep in hospital for at least 3 days after delivery
The Glasgow Coma Scale
| Eyes | 4 3 2 1 | Open spontaneously (already open with blinking) Open to speech Open to pain No response |
| Verbal (exclude if intubated) | 5 4 3 2 1 | Orientated to time and place Confused (still answers questions) Inappropriate words (recognizable but random) Incomprehensible sounds None |
| Motor | 6 5 4 3 2 1 | Obeys command (no pain required) Localises to pain Withdraws (pulls away from a painful stimulus) Decorticate response (abnormal flexion) Decerebrate response (extensor response) No movement |
IMMINENT ECLAMPSIA
- Exclude other causes of headache or abdominal pain – abruptio placentae, simple headache, & send to a high care area. Give paracetamol 1 g orally
- Insert an intravenous drip, give magnesium sulphate (below) & treat the hypertension if BP ≥150/100 mmHg
- Insert a urinary catheter & monitor urine output hourly
- Take blood for U&E, FBC
- Run intravenous fluids at 70 mL/hour
- Do CTG
- Reassess hourly. If imminent eclampsia persists, arrange for delivery
GIVING MAGNESIUM SULPHATE*
Loading dose
- Add magnesium sulphate 4 g to 200 mL normal saline & run the infusion rapidly.
Maintenance dosage
- Add magnesium sulphate 10 g to 200 mL normal saline & run the infusion at 20 mL/hour, equivalent to 1 g/hour.
Alternative regimen
- Dilute magnesium sulphate 4 g (8 mL) in 12 mL saline & give IV over 4 minutes, with 5 g IM in each buttock with 1 mL 1% lidocaine (total 14 g). Maintenance is 5 g IM 4 hourly, in alternate buttocks, with lidocaine.
Precautions during magnesium sulphate infusion
Maintenance doses should only be continued if the following hourly observations are made & confirmed:
- Presence of patellar reflexes,
- The respiratory rate is ≥12 breaths/minute, &
- Urine output is ≥100 mL in the last 4 hours
Treatment of suspected overdose
- The symptoms & signs of overdose are a feeling of extreme weakness, decreased respiratory rate, & absent tendon reflexes
- Take blood for magnesium level
- Give 10% calcium gluconate 10 mL IV slowly, then observe closely
Blood magnesium levels
- Normal range 0.7-1.0 mmol/L, therapeutic at 1.25-3.25, absent reflexes at 4-5, respiratory depression at 6-8, cardiac arrest at >15 mmol/L